2012 HCPCS Q0174
Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

  • This is the 2012 version of HCPCS Q0174 - please refer to the 2016 HCPCS code set for the latest version.
  • Added on Wednesday, April 01, 1998
  • Status changed on Wednesday, April 01, 1998 to: No maintenance for this code
  • BETOS Classification: Chemotherapy
  • Medicare coverage status: Special coverage instructions apply

  Q0173    Q0175